Equity
€33,212 ▲ 26.1%
InForm paid out €1,666 in dividends. That is 19% of the 2025 profit.
InForm
Lifetime
4 annual accounts with figures on one time axispeak €42,969 (2024)
€42,268▼ 1.6%
lowest -€19,853 (2022)
€8,549▼ 38.4%
peak €33,212 (2025)
€33,212▲ 26.1%
€284,544▼ 3.0%
Board3 names since 2021
2 directors and 1 other
Documentsfilings and deeds
25-08-202625 days late
2025micro format
Result from €13,870 to €8,549Dividend €1,666Equity from €26,329 to €33,212
Key points
from the 2025 annual accountsTurnover
≈ €130,000 estimated
The micro format states no turnover.
Debts
€284,544 90% of the balance sheet
Financial debts 72%Suppliers 5%Taxes and wages 4%Other 18%
Of this, €79,110 falls due within a year.
Filings
4 annual accounts 4 late
The 2022 accounts came latest: 262 days after the end of the period.
Starting capital
€10,000 100 shares
Position in the sector
10.5%
Lower solvency than 85% of companies in human health. Sector median 63.0% · 21,311 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,272 companies had the same profile as InForm has now. Each dot stands for 9 companies, two years later.
94.7%
were still trading
2.5%
stopped another way
2.5%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,272 companies, not a prediction for InForm. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 19-03-2021
Director, since 30-04-2024
- 50 sharesdeed of 23-03-2021
- 50 sharesdeed of 23-03-2021
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0765426901
Resignation: (director)
Appointment: (director) · Director discharge: · General meeting of 30-04-2024 · Gazette deed
Incorporation
Founding capital of €10,000, 100 shares · Founders: and · Appointments: (director) and (director) · published on 23-03-2021 · Gazette deed
First establishment
Doorniksesteenweg 23, Avelgem
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| InForm Avelgem | €317,756 | €42,268 | 10.5% | - |
| MARET PARAMED Orp-Jauche | €314,324 | €38,567 | 15.8% | 0 |
| De Kikkersprong Kortrijk | €256,240 | €44,965 | 33.1% | - |
| Kinesitherapie Thomas Stuijk Diksmuide | €289,351 | €37,312 | 19.2% | - |
| Kine Vandenbroele Ilse Torhout | €268,899 | €53,191 | 34.6% | - |
| SIMON LIEFOOGHE Poperinge | €312,803 | €42,249 | 12.7% | - |
| ELEMENT 6-MOVING Braine-le-Comte | €341,541 | €41,226 | 19.9% | - |
These companies have the same main activity as InForm: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €256,000 and €342,000, founded between 2019 and 2022.
Official details
Source: KBO- Status
- Active since 19-03-2021Normal situation
- Activity
- PhysiotherapyNACE 86951and 2 others
- Establishment unit
- 2.315.514.8138580 Avelgem, since 19-03-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 12-11-2025
Insights on InForm
InForm files the micro format. That format states no turnover. The gross margin rose from €20,967 in 2022 to €42,268 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about InForm
- What is the company number of InForm?
- The company number of InForm is 0765.426.901. The VAT number is the same number with BE in front: BE 0765.426.901.
- Where is InForm based?
- The registered office is at Doorniksesteenweg 23, 8580 Avelgem.Company details
- What does InForm do?
- According to the KBO register, the main activity is physiotherapy (NACE 86951).
- What is the legal form of InForm?
- InForm is a private limited company (BV).
- When was InForm founded?
- InForm was founded on 19-03-2021.
- Is InForm still active?
- Yes, InForm is an active enterprise in the KBO register.
- What is the turnover of InForm?
- The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €42,268 and 34 comparable companies (NACE 869). It probably lies between €97,000 and €180,000.Financials
- Is InForm profitable?
- In financial year 2025, InForm made a profit of €8,549.
- Where can I find the annual accounts of InForm?
- InForm filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of InForm due?
- InForm must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.